FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Certificates

FDA
Registration Date 18 Jan 2015
Share

DOXIL®

(0)

Medicine Pharmaceuticals Product Number : 59676-960-01

Antineoplastic Agent

Drug Information

Generic
doxorubicin liposomal
NDC Code
59676-960-01
Drug Class
Anthracycline Topoisomerase Inhibitor
Therapeutic Class
Antineoplastic
Dosage form
Solution
Route of Administration
Intravenous Injection
Therapeutic Area
1.Metastatic ovarian 2.Kaposi’s sarcoma

Indication

Ovarian Cancer, AIDS-Related Kaposi's Sarcoma, Multiple Myeloma, (killing cancer cells)